Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR was delisted on the 16th of April, 2019.
56 hedge funds and large institutions have $47.4M invested in Osiris Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
42% more call options, than puts
Call options by funds: $1.26M | Put options by funds: $887K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HR
51
Howe & Rusling
Rochester,
New York
| $42K | +$43.6K | +4,150 | New |
|
52
BlackRock
New York
| $34K | +$35.7K | +3,394 | New |
|
53
Wells Fargo
San Francisco,
California
| $12K | +$12.6K | +1,200 | New |
|
54
Ameriprise
Minneapolis,
Minnesota
| $12K | +$12.7K | +1,209 | New |
|
55
Teacher Retirement System of Texas
Austin,
Texas
| $11K | +$11.8K | +1,120 | New |
|
56
Citigroup
New York
| $2K | +$2K | +190 | New |
|
OSIR Hedge Fund Activity: Q2 2013 in Review
56 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q2 2013, worth a combined $47.4M.
Buyers outnumbered sellers: 56 funds opened new OSIR positions and 0 closed out — a net gain of 56 holders — while 0 added to existing stakes and 0 trimmed.
- 56 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $47.4M of Osiris Therapeutics, Inc. Common Stock stock for Q2 2013.
- 56 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +56 holders.
Based on aggregated 13F filings for Q2 2013.